Page last updated: 2024-12-07

globomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID115071
CHEBI ID5387
MeSH IDM0068053

Synonyms (15)

Synonym
sf-1902a1
glycine, n-(n-(n-(n-(n-(3-hydroxy-2-methyl-1-oxononyl)-n-methyl-l-leucyl)-l-alloisoleucyl)-l-seryl)-l-allothreonyl)-, rho-lactone
brn 5799627
antibiotic sf 1902
antibiotic sf 1902a1
cyclo(l-alloisoleucyl-l-seryl-l-allothreonylglycyl-(2r,3r)-3-hydroxy-2-methylnonanoyl-n-methyl-l-leucyl)
C01700
67076-74-8
GLOBOMYCIN ,
12-butan-2-yl-19-hexyl-6-(1-hydroxyethyl)-9-(hydroxymethyl)-16,18-dimethyl-15-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentazacyclononadecane-2,5,8,11,14,17-hexone
CHEBI:5387
12-(butan-2-yl)-19-hexyl-5,8,11,14-tetrahydroxy-6-(1-hydroxyethyl)-9-(hydroxymethyl)-16,18-dimethyl-15-(2-methylpropyl)-1-oxa-4,7,10,13,16-pentaazacyclononadeca-4,7,10,13-tetraene-2,17-dione
DTXSID10983012
64441-34-5
Q27106746

Research Excerpts

Overview

Globomycin is an antibiotic which inhibits the processing of the prolipoprotein.

ExcerptReferenceRelevance
"Globomycin is an antibiotic which inhibits the processing of the prolipoprotein. "( Preferential selection of deletion mutations of the outer membrane lipoprotein gene of Escherichia coli by globomycin.
Inouye, M; Inukai, M; Nakamura, K; Zwiebel, LJ, 1981
)
1.92

Actions

ExcerptReferenceRelevance
"Globomycin, known to inhibit signal peptidase II, inhibited processing of the recombinant Mip-like protein."( The Chlamydia trachomatis Mip-like protein is a lipoprotein.
Lundemose, AG; Pearce, JH; Penn, CW; Rouch, DA, 1993
)
1.01

Treatment

Globomycin treatment, Triton X-114 separation and mass spectrometry analyses clarified a property of the Rv0679c protein as a lipoprotein.

ExcerptReferenceRelevance
"Globomycin treatment, Triton X-114 separation and mass spectrometry analyses clarified a property of the Rv0679c protein as a lipoprotein."( Association of the Rv0679c protein with lipids and carbohydrates in Mycobacterium tuberculosis/Mycobacterium bovis BCG.
Matsuba, T; Suzuki, Y; Tanaka, Y, 2007
)
1.06
"Treatment with globomycin of B."( Membrane-Bound PenA β-Lactamase of Burkholderia pseudomallei.
Bonomo, RA; Dobos, K; Papp-Wallace, KM; Randall, LB; Schweizer, HP, 2015
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
cyclodepsipeptideA depsipeptide in which the amino and hydroxy carboxylic acid residues are connected in a ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (88)

TimeframeStudies, This Drug (%)All Drugs %
pre-199030 (34.09)18.7374
1990's29 (32.95)18.2507
2000's16 (18.18)29.6817
2010's8 (9.09)24.3611
2020's5 (5.68)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 24.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index24.59 (24.57)
Research Supply Index4.49 (2.92)
Research Growth Index4.40 (4.65)
Search Engine Demand Index29.35 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (24.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.14%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other87 (98.86%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]